Cantex Pharmaceuticals Stock

cantex.comHealthcareFounded: 2002Funding to Date: $67.87MM

Cantex Pharmaceuticals develops novel treatments for inflammatory lung diseases and cancer.

Register for Details

For more details on financing and valuation for Cantex Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Cantex Pharmaceuticals.

Register Today

Other companies like Cantex Pharmaceuticals in the Healthcare sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$809.52MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$396.01MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$1.53B